Discontinuation report ACT DILTIAZEM T

Last updated on 2020-05-14 History
Report ID 115126
Drug Identification Number 02370514
Brand name ACT DILTIAZEM T
Common or Proper name DILTIAZEM T 300MG TAB
Company Name ACTAVIS PHARMA COMPANY
Market Status MARKETED
Active Ingredient(s) DILTIAZEM HYDROCHLORIDE
Strength(s) 300MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 100
ATC code C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for discontinuation Business reasons
Anticipated discontinuation date 2020-05-08
Actual discontinuation date 2020-05-08
Remaining supply date 2020-05-08
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-05-14 French Compare
v1 2020-05-14 English Compare